Literature DB >> 7572598

Peripartum cardiomyopathy.

M B Lampert1, R M Lang.   

Abstract

Congestive heart failure is an uncommon complication of pregnancy with potentially life-threatening consequences. Peripartum cardiomyopathy is a disease of unknown cause in which severe left ventricular dysfunction occurs during late pregnancy or the early puerperium. In the past, the diagnosis of this entity was made on clinical grounds; however, modern echocardiographic techniques have allowed more accurate diagnoses by excluding cases of diseases that mimic the clinical symptoms and signs of heart failure. Risk factors for peripartum cardiomyopathy include advanced maternal age, multiparity, African descent, twinning, and long-term tocolysis. An extensive search for the causes of peripartum cardiomyopathy has been unrevealing. Treatment includes digitalis, diuretic agents, and vasodilators. Anticoagulation is strongly recommended, especially if ventricular function is persistent. The prognosis of peripartum cardiomyopathy is related to the recovery of ventricular function. Caution is advised in recommending subsequent pregnancy, especially if left ventricular dysfunction is persistent.

Entities:  

Mesh:

Year:  1995        PMID: 7572598     DOI: 10.1016/0002-8703(95)90089-6

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  33 in total

1.  Rare variant mutations in pregnancy-associated or peripartum cardiomyopathy.

Authors:  Ana Morales; Thomas Painter; Ran Li; Jill D Siegfried; Duanxiang Li; Nadine Norton; Ray E Hershberger
Journal:  Circulation       Date:  2010-05-10       Impact factor: 29.690

Review 2.  Acute non-traumatic maternal illnesses in pregnancy: imaging approaches.

Authors:  Saween K S Thompson; Stanford M Goldman; Komal B Shah; Phebe C Chen; Louis K Wagner; Frank M Corl; Bharat K Raval; Shela Sheth; Elliot K Fishman; Carl M Sandler
Journal:  Emerg Radiol       Date:  2005-06

3.  Emergency management of decompensated peripartum cardiomyopathy.

Authors:  Indu Lata; Renu Gupta; Sandeep Sahu; Harpreet Singh
Journal:  J Emerg Trauma Shock       Date:  2009-05

Review 4.  Autoimmune mechanisms as the basis for human peripartum cardiomyopathy.

Authors:  Aftab A Ansari; James D Fett; Robert E Carraway; Ann E Mayne; Nattawat Onlamoon; J Bruce Sundstrom
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

5.  Could it be Quetiapine-induced Peripartum Cardiomyopathy?

Authors:  Mandeep Kaler; Rameen Shakur; Hazel I Learner; Andrew Deaner; Richard J Howard
Journal:  Obstet Med       Date:  2013-03-01

6.  Inflammatory Markers-Serum Level of C-Reactive Protein, Tumor Necrotic Factor-α, and Interleukin-6 as Predictors of Outcome for Peripartum Cardiomyopathy.

Authors:  A Sarojini; A Sai Ravi Shanker; M Anitha
Journal:  J Obstet Gynaecol India       Date:  2013-08-14

7.  [Peripartum cardiomyopathy: interdisciplinary challenge].

Authors:  B Löser; S Tank; G Hillebrand; B Goldmann; W Diehl; D Biermann; J Schirmer; D A Reuter
Journal:  Anaesthesist       Date:  2013-05       Impact factor: 1.041

8.  Combined epidural anesthesia and ultrasound guided peripheral nerve block for wound revision in a patient with peripartum cardiomyopathy -A case report-.

Authors:  Tai Kyung Gong; Seong Su Kim
Journal:  Korean J Anesthesiol       Date:  2010-11-25

9.  An obstetric emergency called peripartum cardiomyopathy!

Authors:  Nissar Shaikh
Journal:  J Emerg Trauma Shock       Date:  2010-01

Review 10.  Peripartum cardiomyopathy: review of the literature.

Authors:  Pradipta Bhakta; Binay K Biswas; Basudeb Banerjee
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.